CAR T-Cell therapy Market - Rising Trends, Demands and Business Outlook 2021–2031
According to a new report published by Allied Market Research, titled " CAR T-Cell Therapy Market ", the car T-cell therapy market is worth $1.7 billion in 2021 and is expected to reach $6.1 billion. dollars by 2031, growing at a. CAGR of 13.5% from 2022 to 2031. Chimeric antigen receptor (CAR) T cell therapy treats certain cancers by converting T cells into cells that are more effective in fighting cancer. CAR T-cell therapy is a new targeted approach, which involves the genetic engineering of T cells to target specific receptors on cancer cells. ♦ Get Free Sample PDF: https://www.alliedmarketresearch.com/request-sample/17358 The COVID-19 outbreak is expected to adversely affect the market as a large number of medical colleges and hospitals across the world have been reorganized to increase hospital capacity for patients diagnosed with COVID- 19. The COVID-19 pandemic has had a negative impact on the market as COVID-19 patients are given priority for treatment....